HNRNPA2B1 and neoplasm: Because related studies about hnRNPA2/B1 are still in the laboratory stage, there is still a long way to go for hnRNPA2/B1 gene-targeted therapies for tumor as well as clinical drug research; thus, our research is temporarily unable to use drugs to interfere with hnRNPA2/B1.